Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Rectal Neoplasms × Chemoradiotherapy × Clear all

Status

Unknown 12 Recruiting 9 Completed 6 Active not recruiting 3 Withdrawn 1 Terminated 1 Suspended 1 Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Squamous Cell Carcinoma of Head and Neck 2 Uterine Cervical Neoplasms 1 Rectal Neoplasms 1 Neoplasms 1 Muscle Invasive Bladder Cancer 1 Laryngeal Neoplasms 1 Laryngeal Diseases 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Carcinoma, Squamous Cell 1 Adenocarcinoma Of Esophagus 1

Interventions

Capecitabine 31 Oxaliplatin 29 Fluorouracil 27 Leucovorin 24 Irinotecan 21 Bevacizumab 18 Radiotherapy 14 Cetuximab 14 Radiation 8 Surgical Procedures, Operative 6 Radiotherapy, Intensity-Modulated 5 Chemotherapy, Adjuvant 5 Neoadjuvant Therapy 4 Immunohistochemistry 4 Gene Expression Profiling 4 cediranib 3 Folfox protocol 3 Celecoxib 3 Biopsy 3 Amplified Fragment Length Polymorphism Analysis 3 regorafenib 2 Surveys and Questionnaires 2 Reverse Transcriptase Polymerase Chain Reaction 2 Receptor Protein-Tyrosine Kinases 2 Proctectomy 2 Polymerase Chain Reaction 2 Mitomycin 2 Magnetic Resonance Spectroscopy 2 Gefitinib 2 Floxuridine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02233595 2019-08-13

Rectal PET/MRI

University of California, San Francisco

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡